Tepper Mark 4
4 · Corbus Pharmaceuticals Holdings, Inc. · Filed Jan 5, 2018
Insider Transaction Report
Form 4
Tepper Mark
President and CSO
Transactions
- Award
Stock Option(right to buy)
2018-01-04+175,000→ 175,000 totalExercise: $8.35Exp: 2028-01-04→ Common Stock (175,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on January 4, 2019, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on February 4, 2019.